|
|
Suppliers for
Levalbuterol tartrate
|
Properties | CAS |
661464-94-4 | Formula |
2(C13H21NO3).C4H6O6 |
|
|
3 Registered suppliers
Description : Levosalbutamol tartrate, the R-enantiomer of salbutamol, is a short-acting β2 adrenergic receptor agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD). - Molecular Weight :314.25
- Purity :≥98%
Molecular Formula : C13H21NO3.1/2(C4H6O6) Canonical SMILES : O=C(O)C(O)C(O)C(=O)O.OC1=CC=C(C=C1CO)C(O)CNC(C)(C)C InChI : InChI=1S/C13H21NO3.C4H6O6/c1-13(2,3)14-7-12(17)9-4-5-11(16)10(6-9)8-15;5-1(3(7)8)2(6)4(9)10/h4-6,12,14-17H,7-8H2,1-3H3;1-2,5-6H,(H,7,8)(H,9,10) InChIKey : SQOXPNYIJRDVRE-UHFFFAOYSA-N Solubility : Soluble in DMSO Appearance : White Solid Application : Used in the treatment of asthma and chronic obstructive pulmonary disease (COPD). Storage : Store at -20 °C Synonyms : 1,3-Benzenedimethanol, α1-[[(1,1-dimethylethyl)amino]methyl]-4-hydroxy-, (α1R)-, (2R,3R)-2,3-dihydroxybutanedioate (2:1) (salt); Xopenex HFA; Levosalbutamol tartrate
More details are to be found here
Description : Levosalbutamol tartrate, the R-enantiomer of salbutamol, is a short-acting β2 adrenergic receptor agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD). - Molecular Weight :314.25
- Purity :≥98%
Molecular Formula : C13H21NO3.1/2(C4H6O6) Canonical SMILES : O=C(O)C(O)C(O)C(=O)O.OC1=CC=C(C=C1CO)C(O)CNC(C)(C)C InChI : InChI=1S/C13H21NO3.C4H6O6/c1-13(2,3)14-7-12(17)9-4-5-11(16)10(6-9)8-15;5-1(3(7)8)2(6)4(9)10/h4-6,12,14-17H,7-8H2,1-3H3;1-2,5-6H,(H,7,8)(H,9,10) InChIKey : SQOXPNYIJRDVRE-UHFFFAOYSA-N Solubility : Soluble in DMSO Appearance : White Solid Application : Used in the treatment of asthma and chronic obstructive pulmonary disease (COPD). Storage : Store at -20 °C Synonyms : 1,3-Benzenedimethanol, α1-[[(1,1-dimethylethyl)amino]methyl]-4-hydroxy-, (α1R)-, (2R,3R)-2,3-dihydroxybutanedioate (2:1) (salt); Xopenex HFA; Levosalbutamol tartrate
More details are to be found here
|
|
|
Privileged suppliers
Last update 2024-06-20
|